Who is sponsoring NCT05638958?

NCT05638958 is sponsored by University Hospital, Geneva.

What drugs are being tested in NCT05638958?

Interventions in NCT05638958: Immediate post-extractive Implant placement.

What condition does NCT05638958 study?

NCT05638958 studies Edentulous Alveolar Ridge Atrophy.

Is NCT05638958 still recruiting?

NCT05638958 is currently status unknown. Last updated 6 December 2022.

Last reviewed 2022-12-06 · How we verify

NCT05638958

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Immediate Implants With Customized Abutments

Status unknown NA Last updated 6 December 2022

What this trial tests

NA trial testing Immediate post-extractive Implant placement in Edentulous Alveolar Ridge Atrophy in 80 participants. Status unknown.

Timeline

10 March 2018

Primary endpoint
10 March 2020

10 March 2023

Quick facts

Lead sponsor	University Hospital, Geneva
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	80
Start date	10 March 2018
Primary completion	10 March 2020
Estimated completion	10 March 2023
Sites	1 location across Switzerland

Drugs / interventions tested

Immediate post-extractive Implant placement

Conditions studied

Edentulous Alveolar Ridge Atrophy — all drugs for Edentulous Alveolar Ridge Atrophy →

Sponsor

University Hospital, Geneva

Who can join

18 and older, any sex, with Edentulous Alveolar Ridge Atrophy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tooth extraction is followed by marked alterations of the tissue volume. The resorption process of at least the surrounding mucosa can be altered by using immediate implant placement and additional features such as immediate provisional crown, platform switching and grafting the gap between implant and buccal bone plate. The support of the gingival margin with a provisional crown led to an increase of buccal gingival tissue. Teeth scheduled for extraction will be used to study the effect of a customized healing abutment. The following groups will be randomly assigned: Control: A commercially available healing abutment will be screwed on top of the implant and a collagen sponge will be used to protect the graft. Test: A customized PEEK abutment mimicking the subgingival emergence of the extracted tooth will be screw retained on top of the implant to seal the extraction site.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Edentulous Alveolar Ridge Atrophy

Currently open trials in the same condition.

NCT07104370 — Freeze-dried Bone Allograft vs Autologous Bone Blocks in the Lateral Augmentation of the Jaws · NA · recruiting
NCT05458271 — Cross-linked Volume-stable Collagen Matrix Versus Connective Tissue Graft At Implant Site. · NA · active not recruiting

Other University Hospital, Geneva trials

Trials by the same sponsor.

NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
NCT07267624 — EARLY Antibiotics aDAptation in Severe Pneumonia(The EARLY ADAPT Study) · NA · not yet recruiting
NCT06710210 — Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventi · NA · not yet recruiting
NCT07173348 — Hypnosis on Breathlessness Mastery in Patients With Persistent Dyspnea · NA · not yet recruiting
NCT07129655 — Cholangitis Definition and Treatment After Kasai Hepatoportoenterostomy for Biliary Atresia: TRACK-BA Study (TRacking Ch · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05638958 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University Hospital, Geneva
Last refreshed: 6 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05638958.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing